scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0166-6851(99)00087-0 |
P698 | PubMed publication ID | 10477179 |
P2093 | author name string | Nagel RL | |
Shear HL | |||
Wanidworanun C | |||
P2860 | cites work | Plasmodium falciparum: identification and purification of the phosphoglycerate kinase of the malaria parasite | Q44274527 |
Aldolase activity of a Plasmodium falciparum protein with protective properties | Q47910987 | ||
Expression and cellular localisation of hexokinase during the bloodstage development of Plasmodium falciparum | Q48016227 | ||
A membrane network for nutrient import in red cells infected with the malaria parasite | Q48036713 | ||
Inhibition of Plasmodium falciparum proliferation in vitro by ribozymes | Q48036924 | ||
Regular initiation of translation of Plasmodium berghei aldolase-2 after pre-mRNA splicing | Q48085448 | ||
Ribozyme therapeutics | Q56883937 | ||
A colorimetric serum glucose determination using hexokinase and glucose-6-phosphate dehydrogenase | Q70640262 | ||
Inhibition of human interferon-gamma expression by antisense oligodeoxynucleotides | Q72756706 | ||
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Human malaria parasites in continuous culture | Q28131626 | ||
Plasmodium falciparum aldolase: gene structure and localization | Q28247447 | ||
Expression of Plasmodium falciparum lactate dehydrogenase in Escherichia coli | Q28270273 | ||
Molecular analysis of Plasmodium falciparum hexokinase | Q30041881 | ||
Cloning of the triosephosphate isomerase gene of Plasmodium falciparum and expression in Escherichia coli | Q30042866 | ||
Inhibition of Plasmodium falciparum malaria using antisense oligodeoxynucleotides | Q33634156 | ||
Drug-resistant malaria in children and in travelers. | Q36704724 | ||
Antimalarial activities of oligodeoxynucleotide phosphorothioates in chloroquine-resistant Plasmodium falciparum | Q37200628 | ||
Antisense oligonucleotide inhibition of gene expression: application to endocrine systems. | Q38309662 | ||
Glycolytic pathway of the human malaria parasite Plasmodium falciparum: primary sequence analysis of the gene encoding 3-phosphoglycerate kinase and chromosomal mapping studies | Q38335737 | ||
Progress in antisense oligonucleotide therapeutics | Q38363412 | ||
Novel biochemical pathways in parasitic protozoa | Q38715992 | ||
Molecular therapy for renal diseases | Q39182534 | ||
The treatment of malaria | Q39590029 | ||
Chemically modified RNA: approaches and applications | Q40484538 | ||
Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides. | Q40505939 | ||
Parasite-regulated membrane transport processes and metabolic control in malaria-infected erythrocytes | Q40539958 | ||
Antisense oligonucleotides as therapeutic agents--is the bullet really magical? | Q40834751 | ||
Malaria chemoprophylaxis for the traveler | Q40913946 | ||
Antisense-oligonucleotide therapy | Q40929324 | ||
Energy metabolism during apoptosis. Bcl-2 promotes survival in hematopoietic cells induced to apoptose by growth factor withdrawal by stabilizing a form of metabolic arrest | Q41127037 | ||
Antisense oligonucleotides: towards clinical trials | Q41297750 | ||
Towards genomic drug therapy with antisense oligonucleotides | Q41337511 | ||
Identification and purification of glucose phosphate isomerase of Plasmodium falciparum | Q44265948 | ||
P433 | issue | 1 | |
P921 | main subject | Plasmodium falciparum | Q311383 |
malaria | Q12156 | ||
P304 | page(s) | 91-101 | |
P577 | publication date | 1999-07-01 | |
P1433 | published in | Molecular and Biochemical Parasitology | Q15752756 |
P1476 | title | Antisense oligonucleotides targeting malarial aldolase inhibit the asexual erythrocytic stages of Plasmodium falciparum | |
P478 | volume | 102 |
Q43569857 | Aldolase genes of Plasmodium species |
Q33679330 | Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis |
Q92639063 | Clearance dynamics of lactate dehydrogenase and aldolase following antimalarial treatment for Plasmodium falciparum infection |
Q34058745 | Clinical proteomics of the neglected human malarial parasite Plasmodium vivax |
Q41276143 | Computational analysis of Plasmodium falciparum metabolism: organizing genomic information to facilitate drug discovery |
Q39347980 | Diagnosis of schistosomiasis using recombinant fructose-1,6-bisphosphate aldolase from a Formosan strain of Schistosoma japonicum |
Q34086895 | Directional gene expression and antisense transcripts in sexual and asexual stages of Plasmodium falciparum |
Q34792277 | Exploiting unique structural and functional properties of malarial glycolytic enzymes for antimalarial drug development |
Q30046331 | Identification and recombinant expression of glyceraldehyde-3-phosphate dehydrogenase of Plasmodium falciparum |
Q40599458 | Inhibition of Plasmodium falciparum proliferation in vitro by antisense oligodeoxynucleotides against malarial topoisomerase II. |
Q37718844 | Potential biomarkers and their applications for rapid and reliable detection of malaria |
Q34240829 | Reconstruction and flux-balance analysis of the Plasmodium falciparum metabolic network. |
Q33550603 | The Alveolate Perkinsus marinus: biological insights from EST gene discovery |
Q24813703 | Transcriptome analysis of antigenic variation in Plasmodium falciparum--var silencing is not dependent on antisense RNA |
Q34671258 | Transcriptome sequencing and analysis of the zoonotic parasite Spirometra erinacei spargana (plerocercoids). |
Q28539036 | Use of peptide nucleic acids to manipulate gene expression in the malaria parasite Plasmodium falciparum |